NEW PROPOSED EUROPEAN COMMISSION PHARMACEUTICAL REGULATION - POTENTIAL CHANGES AND IMPACT ON BIOSIMILARS

被引：0
|
作者：
Yap, B. [1 ]
Watts, M. [2 ]
机构：
[1] Decis Consulting, Croydon, England
[2] Decis Consulting, Ruislip, Kent, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR151
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [1] NEW PROPOSED EUROPEAN COMMISSION PHARMACEUTICAL REGULATION - POTENTIAL CHANGES AND IMPACT ON MANUFACTURERS WITH A FOCUS ON EASTERN & SOUTHERN EUROPEAN MEMBER STATES
    Yap, B.
    Sood, M.
    Tomassy, J.
    Tamayo, M., I
    VALUE IN HEALTH, 2023, 26 (12) : S272 - S272
  • [2] ORPHAN DRUGS - HOW WILL THE NEW PROPOSED EUROPEAN UNION (EU) COMMISSION PHARMACEUTICAL REGULATION IMPACT THERAPIES FOR RARE DISEASES?
    Yap, B.
    Tomassy, J.
    Hinds, C. S.
    VALUE IN HEALTH, 2023, 26 (12) : S287 - S287
  • [3] Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
    Vogler, Sabine
    Schneider, Peter
    Zuba, Martin
    Busse, Reinhard
    Panteli, Dimitra
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] The Potential Impact of the European Commission's Proposed Al Act on SMEs
    Gassauer, Jakob
    Burch, Gerald F.
    ISACA Journal, 2023, 2 : 31 - 35
  • [5] New European Commission animal transport regulation
    不详
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2003, 23 (12) : 538 - 538
  • [6] Assigning Obligations in AI Regulation: A Discussion of Two Frameworks Proposed By the European Commission
    Mattis Jacobs
    Judith Simon
    Digital Society, 2022, 1 (1):
  • [7] Potential changes to the FDA approach to biosimilars have a global impact
    Kurki, Pekka
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2018, 7 (02): : 53 - 55
  • [8] POTENTIAL IMPACT OF THE BIOSIMILARS INTRODUCTION OF 3 ANTI-TNFS IN THE EUROPEAN MARKET
    Psachoulia, E.
    Martin-Rinconada, M. C.
    Levysohn, A.
    VALUE IN HEALTH, 2017, 20 (05) : A143 - A143
  • [9] A systematic review of the European pharmaceutical market and the impact of European Union regulation and jurisdiction
    Van Ginneken, EJ
    Schreyögg, J
    Gericke, CA
    Busse, R
    VALUE IN HEALTH, 2005, 8 (06) : A188 - A188
  • [10] The impact of European Commission merger regulation on US domestic M&As
    Deshpande, Shreesh
    Svetina, Marko
    Zhu, Pengcheng
    JOURNAL OF MULTINATIONAL FINANCIAL MANAGEMENT, 2016, 36 : 1 - 15
12345